Views for Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults.
Total visits
views | |
---|---|
Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults. | 301 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Wecker_M_2012.pdf | 277 |
Wecker_M_2012.pdf(legacy) | 63 |
Top country views
views | |
---|---|
United States | 149 |
South Africa | 48 |
Sweden | 26 |
Germany | 16 |
Vietnam | 9 |
China | 8 |
Netherlands | 8 |
Ireland | 6 |
Finland | 4 |
Russia | 3 |
Singapore | 3 |
Brazil | 2 |
Canada | 2 |
India | 2 |
France | 1 |
Iraq | 1 |
South Korea | 1 |
Pakistan | 1 |
Poland | 1 |
Top city views
views | |
---|---|
Ashburn | 79 |
Johannesburg | 20 |
Des Moines | 10 |
Hanoi | 9 |
Dublin | 6 |
Andover | 4 |
Pretoria | 4 |
Washington | 4 |
Bengaluru | 2 |
Cape Town | 2 |
Mountain View | 2 |
Santa Clara | 2 |
Seattle | 2 |
Chizhou | 1 |
Denver | 1 |
Heidelberg | 1 |
Karachi | 1 |
Rio de Janeiro | 1 |
Secaucus | 1 |
Singapore | 1 |
Stellenbosch | 1 |
São Paulo | 1 |
Tzaneen | 1 |
Villieria | 1 |
West Palm Beach | 1 |